|
Goldman
Philanthropic Partnerships
Sample Partnership Letter
June 13, 2003
By e-mail
John
Smith, MD
Innovation Cancer Center
175 State Ave.
Chicago, IL 60000
Dear Dr.
Smith:
Thank you
for taking the time to talk to me about a potential funding
co-sponsorship between the Innovation Cancer Center (ICC) and
the Goldman Philanthropic Partnerships (GPP).
Your institution is doing so many great things with a
terrific supporting cast.
It is our hope that an association with GPP will just
add one more item to an impressive list of ICC activities.
I
provided you with a very brief overview of the funding
partnerships that we have established with Mayo Clinic,
University of Arizona College of Medicine, the International
Myeloma Foundation, and the Kidney Cancer Association.
All of these co-ventures share the same
characteristics. Our
partner shares our desire to find a cure for disease.
Each partner is interested in using a small portion of
an overall research budget to support very innovative,
frontier research, the type of project that they might
otherwise not be able to fund, but that they know could change
the course of research and cure.
Each partner wants to maintain control over the
solicitation and validation of the research, and to
participate in the funding and management of the research.
And each partner is willing to rely on us to help them
further these goals, without having to give us anything but a
chance to partner.
Just to
make sure I explained how this would work with ICC, I’ll
describe it again here.
Co-sponsorship of innovative research
- GPP
would enter into a simple co-sponsorship with ICC to
co-fund one or more innovative research projects at ICC.
- Once
we have an agreement in place, ICC would solicit specific
innovative research proposals from its faculty that could
have a significant and immediate impact on cancer or other
catastrophic diseases.
- These
research proposals would be reviewed, revised and then
validated by ICC research advisors.
- ICC
would forward to GPP those validated proposals the ICC
research advisors thought were most promising and which
met the GPP innovative research definition (see attached).
- ICC
would agree to fund at least 50% of the project through
funds available at ICC, or by bringing in additional
co-sponsors.
- GPP
science advisors would help us validate the ICC projects
and select those projects that fit our model, and then GPP
would agree to fund up to 50% of the project.
Dr.
Smith, there are many advantages to this type of partnership.
ICC can effectively double it’s funding for these
types of projects, as we will be funding up to fifty percent.
ICC can expand its donor base through our solicitation
of our donors to participate in these ICC co-ventures.
ICC can find support for new researchers looking to
find a foothold, or support for senior researchers looking to
validate a new idea. ICC
can fund a new category of innovative research that could have
a huge impact on the cure for cancer, and have a partner in
GPP willing to share the risk.
I am
available as needed to discuss this further with you and your
development director at any time.
Please let me know how you wish to proceed.
I look forward to hearing from you soon.
Sincerely,
Dr.
Bruce E. Bloom
Chief Science Officer
Goldman Philanthropic Partnerships
70 West Madison Street, Suite 1500
Chicago, IL 60602
312-780-3440
Bruce@GoldmanPartnerships.org
|
